Next revolution in molecular theranostics: personalized medicine for urologic cancers.
about
Rationale of hyperthermia for radio(chemo)therapy and immune responses in patients with bladder cancer: Biological concepts, clinical data, interdisciplinary treatment decisions and biological tumour imaging.Antibody therapeutics for treating prostate cancer: where are we now and what comes next?Clinical impact of 68 Ga-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in patients with prostate cancer with rising prostate-specific antigen after treatment with curative intent: preliminary anaThe New Age of -omics in Urothelial Cancer - Re-wording Its Diagnosis and Treatment.Bio-Inspired Protein-Based Nanoformulations for Cancer Theranostics.
P2860
Next revolution in molecular theranostics: personalized medicine for urologic cancers.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Next revolution in molecular theranostics: personalized medicine for urologic cancers.
@en
type
label
Next revolution in molecular theranostics: personalized medicine for urologic cancers.
@en
prefLabel
Next revolution in molecular theranostics: personalized medicine for urologic cancers.
@en
P2093
P2860
P356
P1433
P1476
Next revolution in molecular theranostics: personalized medicine for urologic cancers
@en
P2093
Carlos Artigas
Fouad Aoun
Hampig Raphael Kourie
P2860
P304
P356
10.2217/FON.15.104
P407
P577
2015-01-01T00:00:00Z